Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Syndax Pharmaceuticals (SNDX) Times Interest Earned (2020 - 2025)

Syndax Pharmaceuticals has reported Times Interest Earned over the past 6 years, most recently at -$17338.2 for Q2 2025.

  • For Q2 2025, Times Interest Earned fell 951.28% year-over-year to -$17338.2; the TTM value through Mar 2026 reached -$55882.2, down 977.44%, while the annual FY2025 figure was -$45514.0, 113.4% down from the prior year.
  • Times Interest Earned for Q2 2025 was -$17338.2 at Syndax Pharmaceuticals, up from -$41878.5 in the prior quarter.
  • Over five years, Times Interest Earned peaked at $777.14 in Q4 2024 and troughed at -$41878.5 in Q1 2025.
  • A 5-year average of -$4689.2 and a median of -$945.73 in 2022 define the central range for Times Interest Earned.
  • Biggest five-year swings in Times Interest Earned: plummeted 43635.16% in 2021 and later soared 162.85% in 2024.
  • Year by year, Times Interest Earned stood at -$13678.4 in 2021, then soared by 92.85% to -$977.51 in 2022, then decreased by 26.5% to -$1236.6 in 2023, then soared by 162.85% to $777.14 in 2024, then tumbled by 2331.04% to -$17338.2 in 2025.
  • Business Quant data shows Times Interest Earned for SNDX at -$17338.2 in Q2 2025, -$41878.5 in Q1 2025, and $777.14 in Q4 2024.